Detalles de la búsqueda
1.
The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
Cancer
; 130(6): 927-935, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985357
2.
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial.
Breast Cancer Res Treat
; 205(1): 87-95, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291268
3.
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.
Int J Cancer
; 151(4): 616-622, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403708
4.
Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.
Int J Hyperthermia
; 34(4): 407-414, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28705099
5.
First-Line Palliative HER2-Targeted Therapy in HER2-Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab-Based Therapy.
Oncologist
; 22(8): 901-909, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533475
6.
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Cancer
; 122(19): 2961-70, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27315546
7.
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Breast Cancer Res Treat
; 156(3): 557-566, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27060914
8.
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Breast Cancer Res Treat
; 154(1): 171-80, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467044
9.
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.
NPJ Breast Cancer
; 9(1): 61, 2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452019
10.
Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer.
JAMA Netw Open
; 5(11): e2244350, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36449290
11.
Neutrophil-guided dosing of anthracycline-cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study.
Med Oncol
; 32(4): 113, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25772511
12.
Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair.
J Pharm Biomed Anal
; 114: 416-25, 2015 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26119504
13.
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.
Cancer Treat Rev
; 41(2): 187-96, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25533736
14.
Denosumab in breast cancer treatment.
Eur J Pharmacol
; 717(1-3): 12-9, 2013 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23545361
Resultados
1 -
14
de 14
1
Próxima >
>>